Guidance was cut as uninsured utilization and deferred elective surgeries overwhelmed volume growth and Medicaid payment benefits.
| Quarter | Q2 FY26 |
|---|---|
| Call date | 2026-07-22 |
| Length | 43 minutes |
| EPS | $-0.19 |
| EPS consensus | $-0.18 |
| Revenue | $2.8B |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
Other quarters: Q2 FY25
All CYH earnings ยท Back to CYH overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.